Diagnosis and management of the poisoned child

Pediatric Annals

Volumn 34, Issue 12, 2005, Pages 936-946

  Barry, J Dave ^a,b,c  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b San Antonio Uniformed Services Health Education Consortium   (United States)

^c U S ARMY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ACETYLSALICYLIC ACID; ACTIVATED CARBON; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDOTE; ANTIHISTAMINIC AGENT; ATROPINE PLUS DIPHENOXYLATE; BRODIFACOUM; CARBAMAZEPINE; CARBON MONOXIDE; CAUSTIC AGENT; COCAINE; DAPSONE; DICHLOROMETHANE; ETHYLENE GLYCOL; HYDROCARBON; IPECAC; IRON; LITHIUM; MEPROBAMATE; METHANOL; MONOAMINE OXIDASE INHIBITOR; OPIATE; POISON; SALICYLIC ACID; SULFONYLUREA DERIVATIVE; THEOPHYLLINE; THYROID HORMONE; CHARCOAL; EMETIC AGENT;

ANAMNESIS; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; EMERGENCY HEALTH SERVICE; ENVENOMATION; FIRST AID; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPERVENTILATION; HYPOTENSION; HYPOTHERMIA; INTESTINE LAVAGE; INTOXICATION; LABORATORY TEST; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MIOSIS; MYDRIASIS; PEDIATRICIAN; PHYSICAL EXAMINATION; POISON CENTER; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; STOMACH LAVAGE; SUICIDE; SYMPTOM; CLASSIFICATION; DELAYED RELEASE FORMULATION; METHODOLOGY; TOXICOLOGY;

ANTIDOTES; CHARCOAL; CHILD; DELAYED-ACTION PREPARATIONS; EMETICS; GASTRIC LAVAGE; HUMANS; IPECAC; MEDICAL HISTORY TAKING; POISONING; POISONS; TOXICOLOGY; TRIAGE;

EID: 84861294944     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20051201-09     Document Type: Review

References (48)

1. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22(5):335-404.
2. Wright N. An assessment of the unreliability of the history given by self-poisoned patients. Clin Toxicol. 1980;16(3):381-384.
3. Hack JB, Hoffman RS. General management of poisoned patients. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: A Comprehensive Study Guide. 5th ed. New York, NY: McGraw-Hill; 2000:1057-1062.
4. Kulig K. Toxicologic problems: general management principles. In: Rosen P, Barkin R, Danzl DF, et al. Emergency Medicine: Concepts and Clinical Practice. 4th ed. St. Louis, MO: Mosby; 1998:1244-1249.
5. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002;20(5):391-452.
6. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21(5):353-421.
7. Goldfrank LR, Flomenbaum NE, Lewin NA, et al. Vital signs and toxic syndromes. In: Goldfrank, LR, Flomenbaum NE, Lewin NA, et al., eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York, NY: McGraw-Hill; 2002:255-260.
8. Krenzelok EP, Leikin JB. Approach to the poisoned patient. Dis Mon. 1996;42(9):509-607.
9. Olson KR, Pentel PR, Kelley MT. Physical assessment and differential diagnosis of the poisoned patient. Med Toxicol. 1987;2(1):52-81.
10. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):699-709.
11. Chomchai CG. Ipecac syrup. In: Olson KR, ed. Poisoning & Drug Overdose. 4th ed. New York, NY: Lange Medical Books/McGraw-Hill; 2004:228-229.
12. Tenenbein M, Cohen S, Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med. 1987;16(8):838-841.
13. Saincher A, Sitar DS, Tenenbein M. Efficacy of ipecac during the first hour after drug ingestion in human volunteers. J Toxicol Clin Toxicol. 1997;35(6):609-615.
14. Neuvonen PJ, Vartiainen M. Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol. 1983;24(4):557-652.
15. Young WF Jr, Bivins HG. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis. Ann Emerg Med. 1993;22(9):1423-1427.
16. Auerbach PS, Osterloh J, Braun O, et al. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann Emerg Med. 1986;15(6):692-698.
17. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust. 1995;163(7):345-349.
18. Merigian KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med. 1990;8(6):479-483.
19. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med. 1985;14(6):562-567.
20. Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Anti Intern Med. 1984;144(1):48-52.
21. McNamara RM, Aaron CK, Gemborys M. Davidheiser S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med. l989;18(9):934-938.
22. Poison treatment in the home. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention. Pediatrics. 2003;112(5):1182-1185.
23. Dershewitz RA, Niederman LG. Ipecac at home - a health hazard? Clin Toxicol. 1981; 18(8):969-972.
24. Garrettson LK. Ipecac home use: we need hope replaced with data. J Toxicol Clin Toxicol. 1991;29(4):515-519.
25. Chafee-Bahamon C, Lacouture PG, Lovejoy FH Jr. Risk assessment of ipecac in the home. Pediatrics. 1985;75(6):1105-1109.
26. Bond GR. Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics. 2003;112(5):1061-1064.
27. Manoguerra AS, Cobaugh DJ: Guidelines for the Management of Poisonings Consensus Panel. Guideline on the Use of Ipecac Syrup in the Out-of-Hospital Management of Ingested Poisons. American Association of Poison Control Centers. 2004. Available at: http://www.aapcc.org/Finalized PMGdIns/ Ipecac%20Guideline%20-%20 final%20for%20JTCT.pdf. Accessed November 9, 2005.
28. Tucker JR. Indications for, techniques of, complications of and efficacy of gastric lavage in the treatment of the poisoned child. Curr Opin Pediatr. 2000;12(2):163-165.
29. Comstock EG, Faulkner TP, Boisaubin EV, Oslon DA, Comstock BS. Studies on the efficacy of gastric lavage as practiced in a large metropolitan hospital. Clin Toxicol. 1981;18(5):581-597.
30. Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):711-719.
31. Howland MA. Antidotes in depth: activated charcoal. In: Goldfrank, LR, Flomenbaum NE. Lewin NA, et al., eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York. NY: McGraw-Hill: 2002:469-474.
32. Chyka PA, Seger D. Position Statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):721-741.
33. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med. 1991;20(6):648-651.
34. Smilkstein MJ. Techniques used to prevent gastrointestinal absorption of toxic compounds. In: Goldfrank, LR, Flomenbaum NE, Lewin NA, et al., eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York, NY: McGraw-Hill: 2002:44-57.
35. Kearney TE. Charcoal, activated. In: Olson KR, ed. Poisoning & Drug Overdose. 4th ed. New York. NY: Lange Medical Books/McGraw-Hill: 2004:427-428.
36. Position paper: cathartics. J Toxicol Clin Toxicol. 2004;42(3):243-253.
37. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1999;37(6):731-751.
38. Bradberry SM, Vale JA. Multiple-dose activated charcoal: a review of relevant clinical studies. J Toxicol Clin Toxicol. 1995;33(5):407-416.
39. Perrone J, Hoffman RS, Goldfrank LR. Special considerations in gastrointestinal decontamination. Emerg Med Clin North Am. 1994;12(2):285-299.
40. Position paper: whole bowel irrigation. J Toxicol Clin Toxicol. 2004;42(6):843-854.
41. Mannenach M. An update on pediatric toxicology. Pediatric Emergency Medicine Reports. 2004 Aug:93-104.
42. Erdman AR. Hydroxycohalamin. In: Olson KR, ed. Poisoning & Drug Overdose. 4th ed. New York. NY: Lange Medical Books/McGraw-Hill: 2004:453-454.
43. Yuan TH, Kerns WP 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37(4):463-474.
44. Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and heta-blocker poisoning. Toxicol Rev. 2004;23(4):215-222.
45. Lovejoy FH Jr, Robertson WO, Woolf AD. Poison centers, poison prevention, and the pediatrician. Pediatrics. 1994;94(2 Pt 1):220-224.
46. Miller TR, Lestina DC. Costs of poisoning in the United States and savings from poison control centers: a benefit-cost analysis. Ann Emerg Med. 1997;29(2):239-245.
47. Hoecker JL, Dougherty CH, Loney L, Middelkamp JN. Pediatric ingestions and poison control. Mo Med. 1976;73(11):619-621.
48. Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355(9220):2048- 2049.